James Raftery: NICE and value based pricing—is this the end?

Since Andrew Lansley announced in 2010 that the NHS would in future use “value based pricing” in its purchases of pharmaceuticals, civil servants and (more recently) the National Institute for … Continue reading James Raftery: NICE and value based pricing—is this the end? […]